Frankincense (5-Loxin/AprèsFlex).
Patented boswellia. Fast-acting joint relief. Boswellic acids from frankincense resin slow the enzyme that turns arachidonic acid into leukotrienes, part of the signalling behind stiff, achy joints after use.
Reviewed March 2026
- Category
- Herb
- Also filed under
- Joints5 LOXMobility
What Frankincense (5-Loxin/AprèsFlex) is, and what it does.
- Does it work
- Suits people whose knees or hands feel stiff after activity or in cold weather. The AKBA-enriched compositions suit anyone who wants a small daily amount taken with a meal.
- How much to take
- Start with 100mg to 250mg a day of the AKBA-enriched composition, taken with a meal containing fat. The 500mg used in trials is a research condition.
- Time to feel it
- Trials with AKBA-enriched compositions report changes in joint comfort from around five to seven days, with more of the change landing across four to eight weeks.
- The first dose
- Day one is quiet. Absorption depends on bile salts, so a meal containing fat matters more than anything you would notice in the first evening.
- With regular use
- Across four to eight weeks of daily use, trials record joint comfort and mobility measures shifting, with the earliest changes around five to seven days. It builds rather than spikes.
- How well tolerated
- Generally well tolerated, with mild stomach upset the usual complaint. Check with your doctor first if you take blood thinners or medicines the liver processes.
- How it feels
- Nothing dramatic. People describe stairs and first steps in the morning feeling looser, noticed more in what you stop avoiding than as a sensation.
- The overlooked benefit
- AKBA is a low percentage of raw resin, which is why an enriched composition delivers at 100mg to 250mg what a much larger scoop of milled gum resin carries.
100 to 250mg a day is where Frankincense (5-Loxin/AprèsFlex) works.
Source: Sengupta et al., Int J Med Sci, 2010; Vishal et al., Int J Med Sci, 2011
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 25 human trials.
- Joint comfort and physical functionMeta-analysis
- Morning stiffness in weight-bearing jointsRandomised trial
- 5-lipoxygenase inhibition and leukotriene formationIn vitro study
- Human leukocyte elastase inhibitionIn vitro study
Questions people ask about Frankincense (5-Loxin/AprèsFlex).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Boswellic acids act principally on 5-lipoxygenase and leukotriene formation, while curcumin acts on NF-kB driven transcription and the cyclooxygenase arm. Covering both branches is the oldest logic in joint formulation.
EPA displaces arachidonic acid in membrane phospholipids so less substrate reaches the lipoxygenase pathway, while boswellia acts on the enzyme itself. Fewer substrate molecules and a slower enzyme are complementary.
MSM supplies bioavailable sulfur used in glycosaminoglycan sulfation and connective tissue crosslinking, a structural contribution rather than a signalling one. Joint formulas pair the structural and the eicosanoid arms.
Glucosamine feeds glycosaminoglycan synthesis in chondrocytes, supplying the building block while boswellia works on the signalling environment those cells sit in. The two roles do not overlap.
Chondroitin is the dominant sulfated glycosaminoglycan of cartilage and contributes to matrix water retention and compressive resilience. It is the material side of a formula whose boswellia arm is a signalling one.
Type II collagen is the fibrillar scaffold of articular cartilage, and undenatured forms additionally act through oral tolerance signalling in gut associated lymphoid tissue. Both routes differ from boswellia's enzyme inhibition.
Hyaluronan gives synovial fluid its viscoelastic character and lubricates the joint surface, a mechanical contribution distinct from the eicosanoid work boswellia does. Lubrication and signalling are separate needs.
Gingerols act on both cyclooxygenase and lipoxygenase branches, reaching the COX side that boswellic acids largely leave alone. Joint blends have combined the resin and the rhizome traditionally.
Bromelain is a proteolytic enzyme that acts on kinin and fibrin handling in soft tissue, and it also improves the absorption of co-administered actives. Both roles sit outside boswellia's mechanism.
Ascorbate is the required cofactor for prolyl and lysyl hydroxylase, the enzymes that stabilise the collagen triple helix. Without it the structural side of a joint formula cannot be assembled.
Boswellic acids are highly lipophilic and their absorption rises substantially when taken with fat rather than on an empty stomach. A medium chain triglyceride carrier provides that lipid phase inside the formula.
Piperine slows intestinal and hepatic glucuronidation, which raises circulating levels of several poorly bioavailable botanicals in the same formula. It is included mainly for the curcumin arm but affects the whole blend.
Harpagoside brings an iridoid glycoside mechanism to a formula whose boswellia arm is triterpenoid. Traditional joint blends combine unrelated plant chemistries on purpose.
PEA acts on PPAR-alpha and mast cell signalling, a route separate from the lipoxygenase pathway boswellia touches. The two are often layered in comfort formulas.
Boswellic acids are large pentacyclic triterpene acids with very low water solubility, and AKBA is the least soluble of the group. Complexing them with phosphatidylcholine gives a dispersible form that does not rely on a fatty meal alone. This is a delivery mechanism; the exposure difference belongs to each specific preparation.
Lecithin holds a lipophilic resin extract in fine dispersion instead of letting it clump in the gut lumen. Finer dispersion means more surface for bile salts and lipase to act on. The role is formulation rather than pharmacology.
Hydrolysed collagen delivers glycine and proline rich peptides that appear in plasma and supply residues for matrix synthesis. Boswellia contributes nothing to that substrate pool, so the two do different jobs in a joint formula. Complementary rather than interacting.
Vitamin D governs intestinal calcium absorption and is required for normal bone and muscle function. Joint formulas include it as a base nutrient beneath the botanical layer. It works on a separate axis from boswellic acids.
Vitamin K activates osteocalcin and matrix Gla protein, the carboxylated proteins that direct calcium into bone and keep it out of soft tissue. It is paired with vitamin D and calcium on that basis. No interaction with the resin extract is implied.
Magnesium is required by a large share of ATP dependent enzymes and forms part of the bone mineral matrix. It sits in joint and bone formulas as a base nutrient. The relationship to boswellia is co-formulation.
Boron affects how calcium, magnesium and vitamin D are handled in small human balance studies and appears in joint formulas for that reason. The evidence is limited and marker based. Read it as associative.
Silicon is present in connective tissue and orthosilicic acid has been studied against collagen synthesis markers. The mechanism is incompletely mapped and the relationship is associative rather than causal. It appears as a matrix nutrient alongside the botanical.
AKBA acts on the 5 lipoxygenase arm of arachidonic acid metabolism while flavonoids including quercetin have been described acting on the cyclooxygenase arm and on mast cell mediator release in cell work. Together they cover two branches of the same lipid mediator network. This is preclinical mechanism, not a combination trial.
Salicin from willow bark is converted to salicylate, which acts on the cyclooxygenase branch, while boswellic acids act on the lipoxygenase branch. Formulators pair them to cover both. Note that salicylate also affects platelet function, which matters for anyone already on a medicine that does the same.
Resveratrol acts through sirtuin and NF kappa B signalling in cell models, a different node from the 5 lipoxygenase step where AKBA acts. Blends stack the two for coverage of separate mechanisms. The grounding is preclinical and the pairing is a formulation choice.
EGCG contributes catechin antioxidant chemistry that boswellic acids do not, so a combined formula covers both terpenoid and polyphenol systems. There is no direct interaction between them. Also relevant: green tea catechins bind non heme iron in the same meal, which matters if the formula carries iron.
Carnosic acid from rosemary slows oxidation of terpenoid rich material during shelf life. It also carries its own diterpene chemistry that overlaps in the same lipid compartment. Its function in a resin extract product is preservation.
Boswellia serrata and Withania somnifera appear together in classical Ayurvedic joint formulations and in modern products that follow that convention. The withanolides and the boswellic acids are unrelated chemistry. The basis is use history rather than a combination study.
Dihydrolipoic acid regenerates ascorbate and glutathione and moves between aqueous and lipid compartments, which a resin terpenoid does not. Their roles in a formula are separate. Mechanistic pairing with no combination data on record here.
Boswellic acid absorption rises when the dose is taken with food containing fat, because it depends on bile salt and lipase driven micelle formation. Pancreatic lipase is the enzyme that does the fat digestion step. This is why dosing instructions for these extracts specify a meal.
Nothing specific on file for Frankincense (5-Loxin/AprèsFlex). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Frankincense (5-Loxin/AprèsFlex) actually does.
The active constituents of Boswellia serrata are pentacyclic triterpene acids known as boswellic acids, of which 3 O acetyl 11 keto beta boswellic acid, abbreviated AKBA, is the most studied.
AKBA inhibits 5 lipoxygenase at a site distinct from the arachidonic acid binding site, reducing conversion of arachidonic acid into leukotrienes.
AKBA is present at only a low percentage in the crude oleo gum resin, which is why standardised extracts are enriched to a declared AKBA figure rather than sold as raw resin.
Boswellic acids are highly lipophilic with poor aqueous solubility, so absorption depends on bile salt driven micelle formation and rises when the dose is taken with a meal containing fat.
Where Frankincense (5-Loxin/AprèsFlex) comes from.
Frankincense trees are scored so resin bleeds out and hardens into lumps. The lumps are cleaned and washed with solvent to separate the active resin acids from the gummy part, then concentrated until AKBA hits the percentage on the label.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
The bark of the Indian frankincense tree is scored and the exuded oleo gum resin is left to harden into tears, then collected by hand, mostly in central India
Tears are graded by colour and cleanliness, sun dried and cleaned of bark and soil before milling
Milled resin is extracted with a food grade organic solvent that dissolves the resin acids while leaving the water soluble gum polysaccharide behind
The extract is fractionated and washed to raise the boswellic acid content, and for AKBA specific grades the enrichment is directed at that single triterpene acid; residual solvent is removed to specification
AKBA and total boswellic acids are measured by HPLC and batches are blended to a declared percentage such as 20 or 30 percent AKBA
For the AprèsFlex type composition the enriched extract is recombined with the resin's own non volatile oil fraction; the finished powder is then blended with the rest of the joint formula and capsuled or tabletted
Getting Frankincense (5-Loxin/AprèsFlex) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.